Injectable and Topical Peptides in Aesthetic Medicine Mechanisms, Clinical Applications, and Future Potential PRIME Journal The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Pharm D Solutions, LLC Issues Voluntary Nationwide Recall of All Sterile Compounded Drugs Due to a Potential Lack of Sterility Assurance FDA Peptide Therapy Prescription in 2025: Your Safe Guide